Global Sequencing Kits Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Sequencing Kits Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Sequencing Kits Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 5,258.07 Million
Diagram Market Size (Forecast Year)
USD 12,426.48 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Sequencing Kits Market, By Type (Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing), Application (Oncology, Retypeive Health, Clinical Investigation, Agrigenomics and Forensics, Other) End Use (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes Others) – Industry Trends and Forecast to 2029.

Sequencing Kits Market

Sequencing Kits Market Analysis and Size

The technique of figuring out the nucleotide sequence of a given DNA fragment is called DNA sequencing. The chain termination technique invented by Frederick Sanger has been used for the majority of DNA sequencing procedures up to this point. This method employs sequence-specific termination of a DNA synthesis reaction using modified nucleotide substrates. New sequencing techniques, such pyrosequencing, are, nonetheless, capturing a larger portion of the sequencing business. Pyrosequencing is currently producing more genomic data than Sanger DNA sequencing. Genome sequencing has been made possible via pyrosequencing. This method allows bacterial genomes to be sequenced in a single run with multiple times coverage. James Watson's genome was recently sequenced using this method as well.

Data Bridge Market Research analyses that the sequencing kits market which was USD 5258.07 million in 2021, would rocket up to USD 12426.48 million by 2029, and is expected to undergo a CAGR of 11.35% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Sequencing Kits Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing), Application (Oncology, Retypeive Health, Clinical Investigation, Agrigenomics and Forensics, Other) End Use (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Illumina, Inc. (U.S.), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (U.S.), Oxford Nanopore Technologies Plc (U.K.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), BGI Group (China), PacBio (U.S.), Fluidigm (U.S.), ArcherDX, Inc. (U.S.), Takara Bio Inc. (Japan), Bioline (Canada), PerkinElmer Inc. (U.S.)

Market Opportunities

  • Growing demand for third-generation sequencing
  • Advancements in personalized medicines offer growth opportunities

Market Definition

An unbranched biopolymer's primary structure, sometimes wrongly referred to as the primary sequence, is determined through sequencing. The outcome of sequencing is a symbolic linear representation known as a sequence, which neatly condenses most of the sequenced molecule's atomic-level structure.

Sequencing Kits Market Dynamics

Drivers

  • Research and development activities

The terminology like DNA, RNA, and genome or genetic is vital to developing the advanced healthcare sector in the biotech sector. Sequencing kits support continuing research and advancements for the investigations of reagents. Demand is growing the market at a rapid rate.

  • Advancements in Sequencing kits

Certain changes have made buying and distributing sequencing kits more commercially viable, which is much more affordable than previously. This coefficient has sparked a global market expansion, which has boosted the industry's growth. Due to the promotion of an advanced supply chain, possible market leaders have created a pertinent level of competition, which is proving to be highly beneficial for the market for sequencing kits over the forecast period of 2022 to 2029.

  • Rise in the geriatric population

The rising prevalence rates of lifestyle disorders like as diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the worldwide sequencing kits market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the sequencing kits market forward.

Opportunities

  • Increase in the number of research and development activities 

The industry is expanding enormously thanks to the generous investments and financial resources made available for R&D activity at public and private institutions and research labs.

Restraints/Challenges

Sequencing kit industry is exposed to some market-crushing factors during the anticipated seven-year market emergence period, such as experiments on rodents and animals that violate ethical standards, which can restrain the market's growth.

This sequencing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sequencing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Sequencing Kits Market

The COVID-19 pandemic had a favourable effect on the market under investigation since it enhanced demand for sequencing kits in the field of developing treatments and diagnostics. Therefore, the market is expected to maintain its high growth rate over the forecast period due to the growing sequencing-based research and development activities in the development of diagnostic tools or efficient therapies for COVID-19.

Recent Development

  • In August 2021, Asuragen and Pacific Biosciences joined forces to enhance tests for carrier screening and other applications based on AmplideX PCR Chemistry and SMRT Sequencing Technology.

Global Sequencing Kits Market Scope

The sequencing kits market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Sanger Sequencing
  • Next Generation Sequencing
  • Third Generation Sequencing

 Application

  • Oncology
  • Retypeive Health
  • Clinical Investigation
  • Agrigenomics and Forensics
  • Other

End Use

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

Sequencing Kits Market Regional Analysis/Insights

The sequencing kits market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.

The countries covered in the sequencing kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the sequencing kits market due to the eminent players and better genetic science infrastructure.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the focus of various established market players to expand their presence in this particular region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Sequencing Kits Market Share Analysis

The sequencing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sequencing kits market.

Some of the major players operating in the sequencing kits market are:

  • Illumina, Inc. (U.S.)
  • Roche Sequencing (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Agilent Technologies, Inc. (U.S.)
  • Oxford Nanopore Technologies Plc (U.K.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • QIAGEN (Germany)
  • BGI Group (China)
  • PacBio (U.S.)
  • Fluidigm (U.S.)
  • ArcherDX, Inc. (U.S.)
  • Takara Bio Inc. (Japan)
  • Bioline (Canada)
  • PerkinElmer Inc. (U.S.)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The sequencing kits market value is projected USD 12426.48 million by 2029.
The sequencing kits market is projected to grow at a CAGR of 11.35% during the forecast period of 2022-2029.
On the basis of application, the Sequencing Kits Market is segmented into Oncology, Retypeive Health, Clinical Investigation, Agrigenomics and Forensics, Other.
The major players operating in the Sequencing Kits Market are Illumina, Inc. (U.S.), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (U.S.), Oxford Nanopore Technologies Plc (U.K.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), BGI Group (China), PacBio (U.S.), Fluidigm (U.S.), ArcherDX, Inc. (U.S.), Takara Bio Inc. (Japan), Bioline (Canada), PerkinElmer Inc. (U.S.).